Calmare Therapeutics Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Calmare Therapeutics prevailing Real Value cannot be determined due to lack of data. The current price of Calmare Therapeutics is $0.0. Our model approximates the value of Calmare Therapeutics from analyzing the firm fundamentals such as Shares Owned By Institutions of 6.92 %, current valuation of 11.54 M, and Return On Asset of -0.38 as well as examining its technical indicators and probability of bankruptcy.
Calmare Therapeutics Total Value Analysis
Calmare Therapeutics is currently anticipated to have valuation of 11.54 M with market capitalization of 11.09 K, debt of 0, and cash on hands of 12.55 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Calmare Therapeutics fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
11.54 M | 11.09 K | 0 | 12.55 K |
Calmare Therapeutics Investor Information
The company recorded a loss per share of 0.13. Calmare Therapeutics had not issued any dividends in recent years. The entity had 3:2 split on the 17th of March 1981. Based on the key indicators related to Calmare Therapeutics' liquidity, profitability, solvency, and operating efficiency, Calmare Therapeutics is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Calmare Therapeutics Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Calmare Therapeutics has an asset utilization ratio of 30.09 percent. This indicates that the Company is making $0.3 for each dollar of assets. An increasing asset utilization means that Calmare Therapeutics is more efficient with each dollar of assets it utilizes for everyday operations.Calmare Therapeutics Ownership Allocation
Calmare Therapeutics holds a total of 30.38 Million outstanding shares. Almost 93.08 percent of Calmare Therapeutics outstanding shares are held by general public with 6.92 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Calmare Therapeutics Profitability Analysis
The company reported the previous year's revenue of 1.17 M. Net Loss for the year was (3.83 M) with profit before overhead, payroll, taxes, and interest of 771.48 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Calmare Therapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Calmare Therapeutics and how it compares across the competition.
Calmare Therapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Retained Earnings | -63.2 M | |
| Shares Float | 18.2 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Calmare Stock
If you are still planning to invest in Calmare Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Calmare Therapeutics' history and understand the potential risks before investing.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |